Download PDF
CC BY-NC-ND 4.0 · Endosc Int Open 2021; 09(02): E154-E162
DOI: 10.1055/a-1311-1014
Original article

Structured oropharynx, hypopharynx and larynx assessment during routine esophagogastroduodenoscopy improves detection of pre- and early cancerous lesions: a multicenter, comparative study

Alexander Huelsen
1   Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
2   Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
,
Andrew T. St John
1   Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
2   Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
,
Ratna Pandey
3   Department of Gastroenterology, North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand
,
David E. Vokes
4   Department of Otorhinolaryngology, Head & Neck Surgery, Auckland City Hospital, Auckland, New Zealand
,
Jessica J. McMaster
1   Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
2   Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
5   Translational Research Institute, Brisbane, Queensland, Australia
,
Russell S. Walmsley
3   Department of Gastroenterology, North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand
6   Faculty of Medicine, University of Auckland, Auckland, New Zealand
,
Gerald J. Holtmann
1   Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
2   Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia
5   Translational Research Institute, Brisbane, Queensland, Australia
7   Faculty of Health and Behavioural Sciences, University of Queensland, Brisbane, Queensland, Australia
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background and study aims A structured assessment of the oropharynx, hypopharynx and larynx (OHL) may improve the diagnostic yield for the detection of precancerous and early cancerous lesions (PECLs) during routine esophagogastroduodenoscopy (EGD). Thus, we aimed to compare routine EGDs ± structured OHL assessment (SOHLA), including photo documentation with regard to the detection of PECLs.

Patients and methods Consecutive patients with elective EGD were arbitrarily allocated to endoscopy lists with or without SOHLA. All detected OHL abnormalities were assessed by an otolaryngologist-head & neck surgeon (ORL-HNS) and the frequency of PECLS detected during SOHLA vs. standard cohort compared.

Results Data from 1000 EGDs with and 1000 EGDs without SOHLA were analyzed. SOHLA was successful in 93.3 % of patients, with a median assessment time of 45 seconds (interquartile range: 40–50). SOHLA identified 46 potential PECLs, including two benign subepithelial lesions (4.6 %, 95 % CI: 3.4–6.1) while without SOHLA, no malignant and only one benign lesion was found (P < 0.05). ORL-HNS imaging review classified 23 lesions (2.3 %, 95 % CI: 1.5–3.4) as concerning and ORL-HNS clinic assessment was arranged. This identified six PECLs (0.6 %, 95 % CI: 0.2–1.3) including two pharyngeal squamous cell lesions (0.2 %) demonstrating high-grade dysplasia and carcinoma in situ (CIS) and four premalignant glottic lesions (0.4 %) demonstrating low-grade dysplasia and CIS.

Conclusion In the routine setting of a gastrointestinal endoscopy practice precancerous and early cancerous lesions of the oropharynx, hypopharynx, and larynx are rare (< 1 %) but can be detected with a structured assessment of this region during routine upper gastrointestinal endoscopy.



Publication History

Received: 25 July 2020

Accepted: 07 October 2020

Article published online:
25 January 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

Comment to this article:

Endoscopy International Open – recently publishedEndoscopy 2021; 53(03): 341-341
DOI: 10.1055/a-1327-5573

 

  • References

  • 1 AIHW. Australian Institute of Health and Welfare. Cancer data in Australia. Canberra: Australian Institute of Health and Welfare; 2019
    Google Scholar
  • 2 Northern Ireland Cancer Registry QsUB, Centre for Public Health. Cancer incidence, prevalence and survival statistics for Northern Ireland: 1993–2017. 2019
    PubMedGoogle Scholar
  • 3 Gatta G, Botta L, Sanchez MJ. et al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. Eur J Cancer 2015; 51: 2130-2143
    CrossrefPubMedGoogle Scholar
  • 4 Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70: 7-30
    CrossrefPubMedGoogle Scholar
  • 5 Chiu PWY, Uedo N, Singh R. et al. An Asian consensus on standards of diagnostic upper endoscopy for neoplasia. Gut 2019; 68: 186-197
    CrossrefPubMedGoogle Scholar
  • 6 Gogarty DS, Shuman A, OʼSullivan EM. et al. Conceiving a national head and neck cancer screening programme. J Laryngol Otol 2016; 130: 8-14
    CrossrefPubMedGoogle Scholar
  • 7 Screening PDQ, Prevention Editorial B. Oral Cavity, Pharyngeal, and Laryngeal Cancer Screening (PDQ(R)): Health Professional Version. In: PDQ Cancer Information Summaries. Bethesda (MD): National Cancer Institute (US); 2002
    Google Scholar
  • 8 Shuman AG, McKiernan JT, Thomas D. et al. Outcomes of a head and neck cancer screening clinic. Oral Oncol 2013; 49: 1136-1140
    CrossrefPubMedGoogle Scholar
  • 9 Howlader NNA, Krapcho M. et al. SEER Cancer Statistics Review, 1975–2016, National Cancer Institute. Bethesda, MD: 2019 https://seer.cancer.gov/csr/1975_2016/
    PubMedGoogle Scholar
  • 10 Vilaseca I, Bernal-Sprekelsen M, Him R. et al. Prognostic factors of quality of life after transoral laser microsurgery for laryngeal cancer. Eur Arch Otorhinolaryngol 2015; 272: 1203-1210 DOI: 10.1007/s00405-014-3030-6.
    CrossrefPubMedGoogle Scholar
  • 11 Amin MBES, Greene F, Byrd DR. et al. AJCC Cancer Staging Manual (8th edition). New York: Springer International Publishing; 2017
    CrossrefGoogle Scholar
  • 12 Baliga S, Kabarriti R, Jiang J. et al. Utilization of transoral robotic surgery (TORS) in patients with oropharyngeal squamous cell carcinoma and its impact on survival and use of chemotherapy. Oral Oncol 2018; 86: 75-80
    CrossrefPubMedGoogle Scholar
  • 13 Mehanna H, Evans M, Beasley M. et al. Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130: S90-s96 DOI: 10.1017/s0022215116000505.
    CrossrefPubMedGoogle Scholar
  • 14 Pedregal-Mallo D, Sanchez Canteli M, Lopez F. et al. Oncological and functional outcomes of transoral laser surgery for laryngeal carcinoma. Eur Arch Otorhinolaryngol 2018; 275: 2071-2077
    CrossrefPubMedGoogle Scholar
  • 15 Norfleet RG. “Light up the larynx” during upper gastrointestinal endoscopy. JAMA 1977; 237: 120
    CrossrefPubMedGoogle Scholar
  • 16 Katsinelos P, Kountouras J, Chatzimavroudis G. et al. Should inspection of the laryngopharyngeal area be part of routine upper gastrointestinal endoscopy? A prospective study. Digest Liver Dis 2009; 41: 283-288
    CrossrefPubMedGoogle Scholar
  • 17 Kozarek RA. Evaluation of the larynx, hypopharynx, and nasopharynx at the time of diagnostic upper gastrointestinal endoscopy. Gastrointest Endosc 1985; 31: 271-273
    CrossrefPubMedGoogle Scholar
  • 18 Lehman G, Compton M, Meadows J. et al. Screening examination of the larynx and pharynx during upper gastrointestinal panendoscopy. Gastrointest Endosc 1982; 28: 176-178
    CrossrefPubMedGoogle Scholar
  • 19 Mullhaupt B, Jenny D, Albert S. et al. Controlled prospective evaluation of the diagnostic yield of a laryngopharyngeal screening examination during upper gastrointestinal endoscopy. Gut 2004; 53: 1232-1234
    CrossrefPubMedGoogle Scholar
  • 20 Stevens SM, Johnson EA, Pfau PR. et al. Visual evaluation of the larynx and hypopharynx during esophagogastroduodenoscopy: a safety and feasibility study. Surg Endosc 2015; 29: 1209-1215
    CrossrefPubMedGoogle Scholar
  • 21 Watanabe S, Matsuda K, Arima K. et al. Detection of subclinical disorders of the hypopharynx and larynx by gastrointestinal endoscopy. Endoscopy 1996; 28: 295-298
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Beg S, Ragunath K, Wyman A. et al. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut 2017; 66: 1886-1899
    CrossrefPubMedGoogle Scholar
  • 23 Bisschops R, Areia M, Coron E. et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy 2016; 48: 843-864
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Park WG, Shaheen NJ, Cohen J. et al. Quality indicators for EGD. Gastrointest Endosc 2015; 81: 17-30
    CrossrefPubMedGoogle Scholar
  • 25 Cammarota G, Galli J, Agostino S. et al. Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms. Endoscopy 2006; 38: 376-381
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Nakanishi H, Doyama H, Takemura K. et al. Detection of pharyngeal cancer in the overall population undergoing upper GI endoscopy by using narrow-band imaging: a single-center experience, 2009-2012. Gastrointest Endosc 2014; 79: 558-564
    CrossrefPubMedGoogle Scholar
  • 27 Emura F, Baron TH, Gralnek IM. The pharynx: examination of an area too often ignored during upper endoscopy. Gastrointest Endosc 2013; 78: 143-149
    CrossrefPubMedGoogle Scholar
  • 28 OʼSullivan B, Huang SH, Su J. et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 2016; 17: 440-451
    CrossrefPubMedGoogle Scholar
  • 29 Gillison ML, DʼSouza G, Westra W. et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Can Inst 2008; 100: 407-420
    CrossrefPubMedGoogle Scholar
  • 30 Boeing H, Dietrich T, Hoffmann K. et al. Intake of fruits and vegetables and risk of cancer of the upper aero-digestive tract: the prospective EPIC-study. Cancer Cause Control 2006; 17: 957-969
    CrossrefPubMedGoogle Scholar
  • 31 Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-968
    CrossrefPubMedGoogle Scholar
  • 32 Muto M, Minashi K, Yano T. et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 2010; 28: 1566-1572
    CrossrefPubMedGoogle Scholar
  • 33 Yoshimura N, Goda K, Tajiri H. et al. Diagnostic utility of narrow-band imaging endoscopy for pharyngeal superficial carcinoma. World J Gastroenterol 2011; 17: 4999-5006
    CrossrefPubMedGoogle Scholar
  • 34 Ishihara R, Takeuchi Y, Chatani R. et al. Prospective evaluation of narrow-band imaging endoscopy for screening of esophageal squamous mucosal high-grade neoplasia in experienced and less experienced endoscopists. Dis Esoph 2010; 23: 480-486
    CrossrefPubMedGoogle Scholar
  • 35 Ni XG, Wang GQ. The role of narrow band imaging in head and neck cancers. Curr Oncol Rep 2016; 18: 10
    CrossrefPubMedGoogle Scholar